Old Web
English
Sign In
Acemap
>
authorDetail
>
Yi Ping Hsiang
Yi Ping Hsiang
I-Shou University
Biology
Cancer research
Chrysin
Viability assay
Sorafenib
5
Papers
31
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Facile production of chlorophyllides using recombinant CrCLH1 and their cytotoxicity towards multidrug resistant breast cancer cell lines.
2021
PLOS ONE
Yi Ping Hsiang
Yi-Ting Wang
Keng-Shiang Huang
Ting-Yu Huang
Mi-Hsueh Tai
Yu-Mei Lin
Chih-Hui Yang
Jei-Fu Shaw
Show All
Source
Cite
Save
Citations (1)
LABA/LAMA fixed-dose combinations versus LAMA monotherapy in the prevention of COPD exacerbations: a systematic review and meta-analysis.
2020
Therapeutic Advances in Respiratory Disease
Ching-Yi Chen
Wang-Chun Chen
Chi Hsien Huang
Yi Ping Hsiang
Chau-Chyun Sheu
Yung-Che Chen
Meng-Chih Lin
Kuo-An Chu
Cheng Hung Lee
Yu-Feng Wei
Show All
Source
Cite
Save
Citations (1)
Chrysin-induced ERK1/2 Phosphorylation Enhances the Sensitivity of Human Hepatocellular Carcinoma Cells to Sorafenib
2019
Anticancer Research
Ching Ting Wei
Lei-Chin Chen
Yi Ping Hsiang
Yung Jun Hung
Pei Hsuan Chien
Hsiao Lin Pan
Yun Ju Chen
Show All
Source
Cite
Save
Citations (5)
Chrysin Attenuates Cell Viability of Human Colorectal Cancer Cells through Autophagy Induction Unlike 5-Fluorouracil/Oxaliplatin
2018
International Journal of Molecular Sciences
Yueh Ming Lin
Chih I. Chen
Yi Ping Hsiang
Yung Chia Hsu
Kung Chuan Cheng
Pei Hsuan Chien
Hsiao Lin Pan
Chien-Chang Lu
Yun‐Ju Chen
Show All
Source
Cite
Save
Citations (15)
1